ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share
On August 13, ARS Pharmaceuticals (NASDAQ:SPRY) held its second-quarter 2026 earnings call, the first for new President and CEO Donn Casale.
Posts Tagged ‘NASDAQ:SPRY’
10 Best Stocks Under $10 That Could Triple
In this article, we will take a look at some of the best stocks under $10 that currently offer an upside potential of at least 200%.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2026 Earnings Call Transcript
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2026 Earnings Call Transcript May 15, 2026ARS Pharmaceuticals, Inc. misses on earnings expectations.
Northland Highlights ARS Pharmaceuticals, Inc. (SPRY) Needle-Free Therapy as Major Innovation Driver
We recently compiled a list of the 10 Best Biotech Stocks Under $10 to Buy. ARS Pharmaceuticals, Inc. is another best biotech stock under $10 to buy.
10 Best Biotech Stocks Under $10 to Buy
In this article, we will be taking a look at the 10 Best Biotech Stocks Under $10 to Buy.
12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q3 2025 Earnings Call Transcript
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q3 2025 Earnings Call Transcript November 10, 2025ARS Pharmaceuticals, Inc. misses on earnings expectations.
ARS Pharmaceuticals, Inc. (SPRY): A Bull Case Theory
We came across a bullish thesis on ARS Pharmaceuticals, Inc. on Value Degen’s Substack’s Substack by Unemployed Value Degen.
ARS Pharmaceuticals (SPRY) Faces Patent Test as Lupin Files ANDA
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is among the fastest growing small cap stocks to buy.
11 Fastest Growing Small Cap Stocks to Buy
In this article, we will take a look at some of the fastest growing small cap stocks to buy.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q2 2025 Earnings Call Transcript
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q2 2025 Earnings Call Transcript August 13, 2025ARS Pharmaceuticals, Inc. misses on earnings expectations.
Jim Cramer on ARS Pharmaceuticals: “It’s a Great Flier”
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is one of the 16 stocks Jim Cramer recently discussed. A caller asked if it was a good time to buy the stock.
Jim Cramer Discussed These 16 Stocks Recently
On Wednesday, Mad Money host Jim Cramer focused on the surge in investor enthusiasm around three of the market’s most speculative sectors.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2025 Earnings Call Transcript
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q1 2025 Earnings Call Transcript May 14, 2025ARS Pharmaceuticals, Inc. reports earnings inline with expectations.
10 Unstoppable Stocks That Could Double Your Money
Generating significant returns and multiplying their money in the stock market remains a primary goal for most investors.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q4 2024 Earnings Call Transcript
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q4 2024 Earnings Call Transcript March 20, 2025ARS Pharmaceuticals, Inc. beats earnings expectations.
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Q3 2024 Earnings Call Transcript
ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals (SPRY): A Bull Case Theory
We came across a bullish thesis on ARS Pharmaceuticals (SPRY) on Value Degen’s Substack by Unemployed Value Degen.
Where Should You Invest $1000 Right Now?
Before making your next trade and tying up your valuable capital, you’d be wise to consider where the smart money is parking its own investment dollars with the expectation ...
5 Best Biotech Stocks to Buy Under $10
In this article, we discuss the 5 best biotech stocks to buy under $10. If you want to see more stocks in this selection, check out 12 Best Biotech Stocks To Buy Under $10.
Hedge Fund Resource Center
